Maravai LifeSciences Holdings, Inc. (MRVI)

NMS – Real vaqt narxi. Valyuta: USD

5.84

+0.04 (0.60%)

Bozor ochiq: Aug 12, 2026, 2:55 PM EDT

5.81

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

07.08.2026

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript

07.08.2026

Maravai LifeSciences Q2 Earnings Call Highlights

Maravai LifeSciences NASDAQ: MRVI reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its adjusted EBITDA forecast.

06.08.2026

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates

Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.08 per share a year ago.

06.08.2026

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2026, together with other business updates. Key Financial Results: Quarterly revenue of $51.4 million, Net loss of $(21.6) million, and Adjusted EBITDA of $8.7 million; Full year 2026 Adjusted EBITDA guidance raised to $33 million to $35 milli.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Maravai LifeSciences Holdings, Inc. (MRVI)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Maravai LifeSciences Holdings, Inc. (MRVI)

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript

Maravai LifeSciences Q2 Earnings Call Highlights

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript

Maravai LifeSciences Q2 Earnings Call Highlights

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Search stocks

Maravai LifeSciences Holdings, Inc. (MRVI)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Maravai LifeSciences Holdings, Inc. (MRVI)

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript

Maravai LifeSciences Q2 Earnings Call Highlights

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript

Maravai LifeSciences Q2 Earnings Call Highlights

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

Maravai LifeSciences Reports Second Quarter 2026 Financial Results